Latest News Releases From The Newsroom
Sunshine Biopharma Reports Exponential Q1 Revenue Growth; Jaguar Health's Canalevia-CA1 Now Available on Chewy; Albemarle Upgraded: Market Highlights
May 11th, 2023
Sunshine Biopharma, Inc. (Nasdaq: SBFM) has released its 2023 First Quarter Results, showcasing impressive growth. The company reported gross revenues of $4,894,053 as of March 31, 2023, marking an exceptional increase of more than 2,100% compared to. Read more
Barclays Downgrades Northrop Grumman, ROTH MKM Upgrades Roblox: Pre-Market Insights on NOC, RBLX, LTHM, and SPCE
May 11th, 2023
Barclays has downgraded Northrop Grumman Corporation (NYSE: NOC) from Overweight to Equal Weight and lowered the price target from $580 to $450. In pre-market trading, the stock is currently trading at $439.49, down $3.54 or 0.80%. On the other ha. Read more
Earnings Surprise: Veru Struggles, YETI and NICE Beat Expectations, JD.com Surges
May 11th, 2023
Today's pre-market trading session has seen a mixed bag of results from several companies reporting their Q1 or Q2 earnings. Veru Inc. (Nasdaq: VERU) has reported a Q2 loss of $0.48 per share, which is worse than the consensus estimate of $0.33 loss . Read more
Polar Power Takes Charge with New Mobile EV Chargers, Guardforce AI Announces Public Equity Offering and Kaleyra Reports Better-Than-Expected Q1 Loss
May 10th, 2023
Polar Power, Inc. (Nasdaq: POLA) made an exciting announcement regarding its new line of mobile Combined Charging System (CCS) Electric Vehicle (EV) chargers. The company is now accepting advance orders for these chargers, which are expected to. Read more
Mixed Bag of Q1 Earnings: Purple Innovation and Marathon Digital Beat Estimates, Riot Platforms and Vuzix Miss Consensus
May 10th, 2023
Purple Innovation, Inc. (Nasdaq: PRPL) reported a Q1 adjusted loss of $0.12 per share, beating the consensus loss estimate of $0.13 per share. This positive news led to a surge in the company's stock price, with $PRPL trading at $3.14, up $0.64 (25.6. Read more
Upcoming Earnings Reports: Disney, Trade Desk, Unity Software, Robinhood, AppLovin, Cheesecake Factory, and Beyond Meat
May 10th, 2023
Several notable companies are scheduled to report their financial results after the market closes today. Here are the details: The Walt Disney Company (NYSE: DIS) is expected to report earnings per share (EPS) of $0.93 on revenue of $21.78 billion. Read more
Celsius Holdings Upgraded, Nikola Downgraded, and Electronic Arts Receives Price Target Boost: Market Reactions Unfold
May 10th, 2023
Celsius Holdings, Inc. (Nasdaq: CELH) has received a notable upgrade from BofA Securities, shifting its rating from Neutral to Buy. Alongside the upgrade, BofA Securities has raised the price target for CELH to $125 from $98. This positive developmen. Read more
Li Auto and N-able Beat Q1 Expectations, Ballard Power Systems Shows Improvement Despite Losses
May 10th, 2023
Li Auto Inc. (Nasdaq: LI) has released its Q1 earnings report, exceeding market expectations with an earnings per share (EPS) of $0.13. The consensus estimate had predicted an EPS of $0.01. This positive performance has garnered attention in the mark. Read more
Mixed Q1 Results: Rivian Automotive Surges Despite Loss, Virgin Galactic Faces Market Downturn, GoPro Struggles to Meet Expectations
May 10th, 2023
Rivian Automotive, Inc. (Nasdaq: RIVN) released its Q1 financial results, reporting an adjusted net loss of $1.43 per share. This result was slightly better than the consensus estimate of a loss of $1.59 per share. Despite the loss, there seems to be. Read more
CTI BioPharma's Acquisition Deal and Addex Therapeutics' Promising Clinical Study Drive Market Enthusiasm
May 10th, 2023
CTI BioPharma Corp. (Nasdaq: CTIC) has recently made headlines with the announcement of a significant development. The company has entered into a definitive agreement with Swedish Orphan Biovitrum AB, which will acquire CTI in an all-cash transaction. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025Earnings Preview: Credo Technology, MongoDB, and Hafnia in Focus
November 30th, 2025




Member Login